Trial Profile
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients with type 2 diabetes mellitus -a randomized comparative study of vonoprazan vs esomeprazole -
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 11 Sep 2018 Status changed from recruiting to completed.
- 07 Mar 2017 New trial record